(Q38106486)

28 August 2017

title

Inhibition of the mTOR pathway: a possible protective role in coronary artery disease (English)

1 reference

28 August 2017

Giovanni Tarantino

1

1 reference

28 August 2017

Domenico Capone

series ordinal

2

1 reference

28 August 2017

language of work or name

English

0 references

publication date

13 May 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

45

1 reference

28 August 2017

issue

4

1 reference

28 August 2017

page(s)

348-356

1 reference

Non-alcoholic fatty liver disease: further expression of the metabolic syndrome

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Could inflammatory markers help diagnose nonalcoholic steatohepatitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Relationships of PAI-1 levels to central obesity and liver steatosis in a sample of adult male population in southern Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Inflammation is necessary for long-term but not short-term high-fat diet-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Pharmacological characterization of a small molecule inhibitor of c-Jun kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Reduction of JNK1 expression with antisense oligonucleotide improves adiposity in obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Lipotoxicity in macrophages: evidence from diseases associated with the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

The subendothelial extracellular matrix modulates JNK activation by flow

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Epicardial adipose tissue as a source of nuclear factor-kappaB and c-Jun N-terminal kinase mediated inflammation in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Hepatic triglyceride synthesis and nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Serum Bcl-2 concentrations in overweight-obese subjects with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

MEK-ERK inhibition corrects the defect in VLDL assembly in HepG2 cells: potential role of ERK in VLDL-ApoB100 particle assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

JNK and ceramide kinase govern the biogenesis of lipid droplets through activation of group IVA phospholipase A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Short-term modulation of extracellular signal-regulated kinase 1/2 and stress-activated protein kinase/c-Jun NH2-terminal kinase in pancreatic islets by glucose and palmitate: possible involvement of ceramide.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

TOR signaling in growth and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Defining the role of mTOR in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Current development of mTOR inhibitors as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

mTOR and cancer: many loops in one pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

mTOR signaling: implications for cancer and anticancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

ER stress negatively regulates AKT/TSC/mTOR pathway to enhance autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Regulation of translation initiation by FRAP/mTOR

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Growing roles for the mTOR pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Catalase induced expression of inflammatory mediators via activation of NF-kappaB, PI3K/AKT, p70S6K, and JNKs in BV2 microglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Regulation of adipocyte differentiation and insulin action with rapamycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

regulation of peroxisome proliferator-activated receptor-gamma activity by mammalian target of rapamycin and amino acids in adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Anti-atherosclerotic effects of sirolimus on human vascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

mTOR-inhibitors simultaneously inhibit proliferation and basal IL-6 synthesis of human coronary artery endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Everolimus inhibits monocyte/macrophage migration in vitro and their accumulation in carotid lesions of cholesterol-fed rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Sirolimus blocks the accumulation of hyaluronan (HA) by arterial smooth muscle cells and reduces monocyte adhesion to the ECM

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Oral rapamycin inhibits growth of atherosclerotic plaque in apoE knock-out mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Prevention of atherosclerosis by the mTOR inhibitor everolimus in LDLR-/- mice despite severe hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Oral rapamycin attenuates inflammation and enhances stability of atherosclerotic plaques in rabbits independent of serum lipid levels

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Weight gain and obesity after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Effect of mTOR inhibitor on body weight: from an experimental rat model to human transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

GSK-3β at the crossroads in the signalling of heart preconditioning: implication of mTOR and Wnt pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Subcutaneous adipose tissue remodeling during the initial phase of weight gain induced by overfeeding in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Cardiovascular disease in stable renal transplant patients in Norway: morbidity and mortality during a 5-yr follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Obesity and kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Long-term assessment of plasma lipids in transplant recipients treated with tacrolimus in relation to fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Minimization of immunosuppression in kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Endoplasmic reticulum stress markers are associated with obesity in nondiabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Tumor necrosis-like weak inducer of apoptosis as a proinflammatory cytokine in human adipocyte cells: up-regulation in severe obesity is mediated by inflammation but not hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Endoplasmic reticulum stress is reduced in tissues of obese subjects after weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Lipopolysaccharide, high glucose and saturated fatty acids induce endoplasmic reticulum stress in cultured primary human adipocytes: Salicylate alleviates this stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

FFA‐Induced Adipocyte Inflammation and Insulin Resistance: Involvement of ER Stress and IKKβ Pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Asymmetrical dimethylarginine triggers lipolysis and inflammatory response via induction of endoplasmic reticulum stress in cultured adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

DsbA-L alleviates endoplasmic reticulum stress-induced adiponectin downregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

ER stress in adipocytes inhibits insulin signaling, represses lipolysis, and alters the secretion of adipokines without inhibiting glucose transport.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Endoplasmic reticulum stress regulates adipocyte resistin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Grp78 heterozygosity promotes adaptive unfolded protein response and attenuates diet-induced obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Endurance exercise training ameliorates insulin resistance and reticulum stress in adipose and hepatic tissue in obese rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Circadian clock-coordinated 12 Hr period rhythmic activation of the IRE1alpha pathway controls lipid metabolism in mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Dephosphorylation of translation initiation factor 2alpha enhances glucose tolerance and attenuates hepatosteatosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Endoplasmic reticulum is a main localization site of mTORC2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

Inhibition of the mTOR/p70S6K pathway is not involved in the insulin-sensitizing effect of AMPK on cardiac glucose uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.770333

10.3109/07853890.2013.770333

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference